Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Lambert

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Current Opinion in Lipidology|May 15, 2007
Unravelling the functional significance of PCSK9Gilles Lambert
Journal of the American College of Cardiology|December 6, 2023
Lipoprotein(a): More Than Just a Biomarker of Myocardial FibrosisGilles Lambert, Kévin Chemello, Antonio Gallo
Trends in Endocrinology and Metabolism: TEM|February 21, 2006
PCSK9: a promising therapeutic target for dyslipidemias?Gilles Lambert, Michel Krempf, Philippe Costet
Swiss Medical Weekly|April 10, 2015
PCSK9 inhibitorsBaris Gencer, Gilles Lambert, François Mach
Atherosclerosis|March 14, 2019
PCSK9 inhibition for autosomal recessive hypercholesterolemiaKévin Chemello, Cesar Martín, Gilles Lambert
European Heart Journal|July 29, 2021
Heart to heart with PCSK9Kevin Chemello, Ali K Jaafar, Gilles Lambert
Current Opinion in Lipidology|September 11, 2018
Key aspects of PCSK9 inhibition beyond LDL loweringStéphane Ramin-Mangata, Valentin Blanchard, Gilles Lambert
Presse Medicale (Paris, France : 1983)|June 20, 2006
[Physical activity in hypertension management]Xavier Chanudet, Gilles Lambert de Cremeur, Lionel Bonnevie
Journal of Clinical Lipidology|April 11, 2017
Severe decrease in high-density lipoprotein cholesterol with the combination of fibrates and ezetimibe: A case seriesEstelle Nobecourt, Bertrand Cariou, Gilles Lambert, et al.
Medecine Sciences : M/S|December 8, 2004
[PCSK9: a new gene involved in familial hypercholesteremia]Gilles Lambert, Philippe Costet, Michel Krempf, et al.
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Current Opinion in Lipidology|May 15, 2007
Unravelling the functional significance of PCSK9Gilles Lambert
Journal of the American College of Cardiology|December 6, 2023
Lipoprotein(a): More Than Just a Biomarker of Myocardial FibrosisGilles Lambert, Kévin Chemello, Antonio Gallo
Trends in Endocrinology and Metabolism: TEM|February 21, 2006
PCSK9: a promising therapeutic target for dyslipidemias?Gilles Lambert, Michel Krempf, Philippe Costet
Swiss Medical Weekly|April 10, 2015
PCSK9 inhibitorsBaris Gencer, Gilles Lambert, François Mach
Atherosclerosis|March 14, 2019
PCSK9 inhibition for autosomal recessive hypercholesterolemiaKévin Chemello, Cesar Martín, Gilles Lambert
European Heart Journal|July 29, 2021
Heart to heart with PCSK9Kevin Chemello, Ali K Jaafar, Gilles Lambert
Current Opinion in Lipidology|September 11, 2018
Key aspects of PCSK9 inhibition beyond LDL loweringStéphane Ramin-Mangata, Valentin Blanchard, Gilles Lambert
Presse Medicale (Paris, France : 1983)|June 20, 2006
[Physical activity in hypertension management]Xavier Chanudet, Gilles Lambert de Cremeur, Lionel Bonnevie
Journal of Clinical Lipidology|April 11, 2017
Severe decrease in high-density lipoprotein cholesterol with the combination of fibrates and ezetimibe: A case seriesEstelle Nobecourt, Bertrand Cariou, Gilles Lambert, et al.
Medecine Sciences : M/S|December 8, 2004
[PCSK9: a new gene involved in familial hypercholesteremia]Gilles Lambert, Philippe Costet, Michel Krempf, et al.
Pageof 17